Anti-abortion activists have several backup strategies if the Supreme Court rejects the reversal of the FDA's approval of the ...
Anti-abortion activists decried casting abortion rights as a women’s health issue. One such activist, Melanie Salazar, 31 weeks pregnant, had scrawled a message on her bare belly: “Fully Human.” ...
Wade. Kristen Waggoner, ADF’s CEO, president and general counsel, has become the face of the group’s anti-abortion campaign, building a reputation within conservative legal circles as a ...
Roughly 90 minutes of grappling over the abortion drug mifepristone produced some unusual and noteworthy moments.
A Republican judge on Monday found an anti-abortion activist guilty of obstruction after he attempted to cite, among other things, passages from the Bible and his own "deeply held" beliefs.
Baker, whose book, History and Politics of Abortion Pills in the United States, is being published by Amherst College Press this year. Lithwick and Baker discussed the anti-abortion movement’s ...
Skeptics of the anti-abortion doctors warn that their theories would toss open the doors to a flood of new lawsuits – from both liberal and conservative groups – over countless other decisions ...
By Pam Belluck A majority of the justices questioned whether a group of anti-abortion doctors and organizations trying to sharply limit availability of the medication could show they suffered harm.
Remember, majorities in almost every state—including Texas, Alabama, and Florida—believe that abortion should ... delighted as the most vehement anti-choice activist to undermine the right ...
Besides disputing the FDA’s conclusion that the changes it allowed are warranted, the anti-abortion groups challenging mifepristone also argue the FDA is violating the Comstock Act. The long ...
Read coverage of the arguments here. Washington — Twenty months after the Supreme Court ruled to return abortion policy to the states, the issue will be before the justices again on Tuesday ...
A group of anti-abortion rights doctors and medical associations challenged those changes, claiming the FDA violated the law. The Supreme Court is now reviewing a decision from a federal appeals ...